Candesartan cilexetil 32 MG TB 90S
Ended Awarded
- Contract number
- SPE2DB26FDS29
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,889
Award facts
- Contract value 100% obligated
- $22,889.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in a quantity of 90 units, with a ceiling value of $22,889.03. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II receptor antagonist used primarily for hypertension management, supporting military and federal healthcare system pharmaceutical needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen demonstrates significant capability in fulfilling federal medical procurement requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FDS29?
SPE2DB26FDS29 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDS29 worth?
The government has obligated $22,889 on SPE2DB26FDS29.
Is contract SPE2DB26FDS29 an order under another contract?
Yes. SPE2DB26FDS29 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDS29 competed?
The extent of competition for SPE2DB26FDS29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award